Genomma Lab Internacional SAB de CV is a pharmaceutical company based in Mexico with an ESG score of 28.1, indicating a medium-risk level. Specializing in both specialty and generic drugs, Genomma's mission is to enhance and maintain the health of individuals with innovative and safe products. They offer a range of brands catering to various consumer needs such as pregnancy, pain relief, and deodorants. In pursuit of growth, the company is open to mergers and acquisitions to enhance its research, development, manufacturing, and marketing capabilities.